189 related articles for article (PubMed ID: 2480820)
1. Behaviour of serum immunoreactive trypsin after serum activation by enterokinase in normal and cystic fibrosis patients. Evidence of a trypsin-alpha 1-proteinase inhibitor complex in some cystic fibrosis patients.
Carrère J; Chazalette JP; Figarella C
Biochim Biophys Acta; 1989 Dec; 993(2-3):137-42. PubMed ID: 2480820
[TBL] [Abstract][Full Text] [Related]
2. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera.
Brodrick JW; Geokas MC; Largman C; Fassett M; Johnson JH
Am J Physiol; 1979 Nov; 237(5):E474-80. PubMed ID: 91323
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitor and defective proteolysis in cystic fibrosis.
Hsieh MC; Berry HK
Dig Dis Sci; 1988 Mar; 33(3):282-8. PubMed ID: 2449319
[TBL] [Abstract][Full Text] [Related]
4. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
Geokas MC; Largman C; Brodrick JW; Johnson JH
Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
[TBL] [Abstract][Full Text] [Related]
5. Studies on the activation of canine trypsinogens in vitro.
Borgström A; Ohlsson K
Biochim Biophys Acta; 1979 Dec; 571(2):284-93. PubMed ID: 92342
[TBL] [Abstract][Full Text] [Related]
6. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
Massie J; Curnow L; Tzanakos N; Francis I; Robertson CF
Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
[TBL] [Abstract][Full Text] [Related]
7. Determination and characterization of immunoreactive trypsin in amniotic fluid from normal and cystic fibrosis fetuses.
Borgström A; Sveger T; Kullander S; Svanberg L; Hösli P
Pediatr Res; 1984 Oct; 18(10):957-9. PubMed ID: 6333665
[TBL] [Abstract][Full Text] [Related]
8. Neonatal screening for cystic fibrosis, using immunoreactive trypsin assay in dried blood spots.
Crossley JR; Smith PA; Edgar BW; Gluckman PD; Elliott RB
Clin Chim Acta; 1981 Jun; 113(2):111-21. PubMed ID: 7249357
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive trypsins in sera from dogs before and after induction of experimental pancreatitis.
Borgström A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):625-31. PubMed ID: 6159294
[TBL] [Abstract][Full Text] [Related]
10. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoreactive trypsin in cystic fibrosis.
Dandona P; Hodson M; Bell J; Ramdial L; Beldon I; Batten JC
Thorax; 1981 Jan; 36(1):60-2. PubMed ID: 7292384
[TBL] [Abstract][Full Text] [Related]
12. A method for determination of immunoreactive trypsin in complex with alpha 1-antitrypsin in human sera.
Borgström A; Ohlsson K
Scand J Clin Lab Invest; 1984 Sep; 44(5):381-6. PubMed ID: 6333064
[TBL] [Abstract][Full Text] [Related]
13. An Enzyme Immunoassay for Determining Immunoreactive Trypsinogen (IRT) in Dried Blood Spots on Filter Paper Using an Ultra-Microanalytical System.
Castells Martínez EM; González EC; Tejeda Y; Frómeta A; Martín O; Espinosa M; Del Río L; Pérez PL; Morejón G; Perea Y; Melchor A
Appl Biochem Biotechnol; 2018 Dec; 186(4):1034-1046. PubMed ID: 29808455
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive trypsin levels in neonates with meconium ileus.
Steven LC; Gavel G; Young D; Carachi R
Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
[TBL] [Abstract][Full Text] [Related]
15. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
16. Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.
Sontag MK; Lee R; Wright D; Freedenberg D; Sagel SD
J Pediatr; 2016 Aug; 175():150-158.e1. PubMed ID: 27131402
[TBL] [Abstract][Full Text] [Related]
17. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
[TBL] [Abstract][Full Text] [Related]
18. Competition for trypsin binding between alpha 2-macroglobulin and antitrypsin antibodies in cystic fibrosis.
Romeo G; Denaro M; Parsons M
J Lab Clin Med; 1980 Jan; 95(1):116-24. PubMed ID: 6153109
[TBL] [Abstract][Full Text] [Related]
19. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of murine monoclonal antibodies against immunoreactive trypsinogen for newborn screening of cystic fibrosis.
Morejón García G; García de la Rosa I; Feal Carballo S; Castells Martínez EM; Stable Vernier IC; Quintana Guerra JM; Hernández Pérez L; Lafita Delfino Y; Pérez Morás PL; Pupo Infante M; Figueredo Lago JE; González Reyes EC
Anal Biochem; 2020 Feb; 591():113569. PubMed ID: 31887264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
